Stockreport

ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

ZyVersa Therapeutics, Inc.  (ZVSA) 
PDF Inflammasome ASC Inhibitor IC 100 is a next generation drug designed for unparalleled control of disease-causing inflammation by (1) inhibiting multiple inflammasomes a [Read more]